Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma

Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA
Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma ( Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA )
1 Jun 2020

Cumulative incidence of financial hardship in metastatic colorectal cancer patients: Primary endpoint results for SWOG S1417CD

Dr Veena Shankaran - Fred Hutchinson Cancer Research Center, Seattle, USA
Cumulative incidence of financial hardship in metastatic colorectal cancer patients: Primary endpoint results for SWOG S1417CD ( Dr Veena Shankaran - Fred Hutchinson Cancer Research Center, Seattle, USA )
30 May 2020

Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer

Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Association of BRCA alterations with response to PARP inhibitors in metastatic castration-resistant prostate cancer ( Dr Emmanuel Antonarakis - John Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA )
30 May 2020

The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups

Dr Cornelis van Tilburg - Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany
The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups ( Dr Cornelis van Tilburg - Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany )
30 May 2020

Better genetic diagnostics in Ugandan breast cancer patients

Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA
Better genetic diagnostics in Ugandan breast cancer patients ( Dr Julie Gralow - University of Washington School of Medicine, Seattle, USA )
29 May 2020

Sym015 shows superior specificity compared to TKIs for NSCLC

Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA
Sym015 shows superior specificity compared to TKIs for NSCLC ( Dr Ross Camidge - University of Colorado Cancer Center, Aurora, USA )
29 May 2020

COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic

Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK
COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic ( Prof Stephen Johnston - Royal Marsden NHS Foundation Trust, London, UK )
28 May 2020

Pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast cancer

Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain
Pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast cancer ( Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain )
27 May 2020

COM701 as a monotherapy and in combination with nivolumab for various advanced solid tumours

Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA
COM701 as a monotherapy and in combination with nivolumab for various advanced solid tumours ( Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA )
27 May 2020

Diagnosing, treating and managing breast cancer during COVID-19

Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium
Diagnosing, treating and managing breast cancer during COVID-19 ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )
22 May 2020

COVID-19: Risk of millions relapsing back to smoking

Dr Sudhanshu Patwardhan - Centre for Health Research and Education, Southampton, UK
COVID-19: Risk of millions relapsing back to smoking ( Dr Sudhanshu Patwardhan - Centre for Health Research and Education, Southampton, UK )
22 May 2020

A first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 women with no history of cancer

Prof Nickolas Papadopoulos - Johns Hopkins Medicine, Baltimore, USA
A first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 women with no history of cancer ( Prof Nickolas Papadopoulos - Johns Hopkins Medicine, Baltimore, USA )
13 May 2020